Enter your email address to receive notifications of new posts by email.
IsoRay Announces “Long-term PSA Outcomes in a Single Institution, Prospective Randomized Cesium-131 trial… https://t.co/VAnZ2s2JYhabout 19 hours ago
$CBIO Catalyst Biosciences Announces Successful Completion of Subcutaneous Dosing Cohort in Clinical Trial… https://t.co/V8DFbSa5fqabout 19 hours ago
$AST Asterias’ AST-OPC1 Clinical Trial Will Continue Following Recommendation of Data Monitoring Committee… https://t.co/LpJl6tC1Igabout 19 hours ago
$IPCI Intellipharmaceutics Receives Complete Response Letter from the FDA for Rexista™ NDA https://t.co/7mxAPZhg7j https://t.co/3VbcuEazOCabout 19 hours ago
Zomedica Pharmaceuticals Corp. to Present at SeeThruEquity and RHK Capital 2017 Disruptive Growth Company Showcase… https://t.co/bjC16cmVMg4:09 PM Sep 21st
Get every new post delivered right to your inbox.